02 August 2012 08:32

EC raises concern at Visa Europe on credit card interchange fees

Visa Europe

European regulators have formally raised concerns that consumers could be paying too much because of fees charged by Visa to process cross-border credit card transactions.

The European Commission told Visa of its concerns about "possible violations of EU antitrust rules" relating to Visa's "multilateral interchange fees" (MIFs) system, which charges retailers for the transactions they handle. 

In a supplementary statement, the Commission says that its preliminary view is that the Visa multilateral interchange fees (MIFs) for consumer credit cards violate its rules designed to stop cartels and restrictive business practices.

The EC says it thinks that MIFs "harm competition between acquiring banks, inflate the cost of payment card acceptance for merchants and ultimately increase consumer prices".

It also "doubts" that Visa's MIFs are "necessary to create efficiencies that benefit merchants and consumers" and could therefore be entitled to an exception from the rules. 

The supplementary statement is the latest stage in a lengthy battle that saw Visa slash its multilateral interchange fees for debit cards in late 2010 but refuse to back down credit cards.

Visa can now make a written reply or ask for a hearing on the issue which could see fines imposed of up to 10% of turnover imposed for antitrust breaches,

Responding to the new development, Peter Ayliffe, CEO, Visa Europe, says: "We are very disappointed that the Commission has taken such a confrontational approach and was not willing to find a solution to support investment and innovation in European payments for the benefit of European consumers and to allow European payments to compete globally." 

In May an EU court dismissed Visa rival MasterCard's challenge against an EC ruling that the firm's cross-border interchange fees for both credit and debit cards violated competition law.

Meanwhile, both card giants are facing interchange problems in the US: having agreed a $7.25 billion class action settlement with retailers earlier this month, several major merchants, including Walmart, have now come out against the plan.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
26 Jul
 
Pouli,   Forum er i den grad domineret af børn, studerende, ludomaner, buffet-wannabees and what hav..
24
28 Jul
GEN
Der er lidt nyt fra Morphosys angående deres CD38 antistof - det lader heldigvis til at gå lidt lang..
16
28 Jul
 
Dejligt at der er nogen som kan svare "sobert" på et stillet spørgsmål.   Svaret kan indeholde ironi..
12
24 Jul
OMXN40
Det bliver/er hverdagskost i alle europæiske lande inden længe.. Men tankevækkende, at terrortruslen..
12
25 Jul
EXQ
Så lykkedes det at komme til Vedbæk for at besøge Exiqon. Damen, en kammerat og jeg selv blev taget ..
11
23 Jul
PNDORA
Det er helt naturligt, at aktiekursen på et selskab, som er steget meget, svinger kraftigt forud for..
11
27 Jul
 
Jeg har opdateret mine udbyttelister med tilbagekøb.   http://www.proinvestor.com/boards/69564/    
10
28 Jul
VELO
28/07/2014 08:30:00 - OMX Copenhagen, News     VELO: Veloxis Pharmaceuticals A/S - Envarsus ® får ..
9
29 Jul
FING-B
XO/Sologstrand, Mackeith, Vildum, Swiftnick og andre FING-skeptikere   1) Er vi enige i, at markedet..
7
27 Jul
BIOPOR
Alpe, det jeg skriver, skal absolut ikke ses som en meget udenoms forklaring.   men, trist du kun fo..
7

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ATOS :First half 2014 results
2
Klépierre and Corio to create the leading pure play retail property company in Europe
3
Chemtura Reports Second Quarter 2014 Financial Results
4
Orion Group Interim Report January-June 2014
5
Evolving Gold Corp (CSE:EVG) (TSX:EVG) Lists on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
30 July 2014 05:59:43
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20140723.1 - EUROWEB5 - 2014-07-30 06:59:43 - 2014-07-30 05:59:43 - 1000 - Website: OKAY